AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 89 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $19,562,000 | +2268.3% | 326,905 | +1011.5% | 0.18% | +2442.9% |
Q3 2019 | $826,000 | -80.2% | 29,411 | -73.2% | 0.01% | -75.9% |
Q2 2019 | $4,162,000 | +1360.4% | 109,920 | +1405.3% | 0.03% | +866.7% |
Q1 2019 | $285,000 | +99.3% | 7,302 | +43.3% | 0.00% | +200.0% |
Q3 2017 | $143,000 | +3.6% | 5,094 | -32.7% | 0.00% | 0.0% |
Q4 2016 | $138,000 | – | 7,569 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |